Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,599 | 225 | 97.3% |
| Education | $99.95 | 1 | 2.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $456.98 | 40 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $441.06 | 18 | $0 (2024) |
| Corcept Therapeutics | $352.10 | 16 | $0 (2021) |
| Amgen Inc. | $304.08 | 9 | $0 (2022) |
| GlaxoSmithKline, LLC. | $253.12 | 13 | $0 (2024) |
| Novo Nordisk Inc | $173.24 | 37 | $0 (2021) |
| Takeda Pharmaceuticals U.S.A., Inc. | $171.65 | 14 | $0 (2021) |
| Lilly USA, LLC | $163.37 | 13 | $0 (2021) |
| Biohaven Pharmaceuticals, Inc. | $156.12 | 8 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $129.37 | 8 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $369.75 | 16 | Regeneron Healthcare Solutions, Inc. ($123.63) |
| 2023 | $199.74 | 10 | GlaxoSmithKline, LLC. ($100.86) |
| 2022 | $439.57 | 12 | AstraZeneca Pharmaceuticals LP ($149.72) |
| 2021 | $2,690 | 188 | AbbVie Inc. ($456.98) |
All Payment Transactions
226 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $36.84 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/14/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.83 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: Respiratory | ||||||
| 10/16/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $20.80 | General |
| Category: IMMUNOLOGY | ||||||
| 09/26/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.80 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/05/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $24.28 | General |
| Category: Respiratory | ||||||
| 08/15/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/08/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $27.37 | General |
| Category: NEUROLOGY | ||||||
| 07/29/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $25.26 | General |
| Category: IMMUNOLOGY | ||||||
| 07/17/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $38.16 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/11/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: Respiratory | ||||||
| 05/23/2024 | AERIN MEDICAL INC. | VIVAER STYLUS (Device), RHINAER STYLUS | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: EAR NOSE & THROAT | ||||||
| 05/09/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: Respiratory | ||||||
| 04/18/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $26.19 | General |
| Category: IMMUNOLOGY | ||||||
| 04/13/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: Respiratory | ||||||
| 02/01/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $26.19 | General |
| Category: IMMUNOLOGY | ||||||
| 12/26/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $20.62 | General |
| Category: IMMUNOLOGY | ||||||
| 12/15/2023 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $30.06 | General |
| Category: NEUROLOGY | ||||||
| 10/26/2023 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: Respiratory | ||||||
| 10/19/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: IMMUNOLOGY | ||||||
| 08/17/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $24.30 | General |
| Category: IMMUNOLOGY | ||||||
| 07/21/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: IMMUNOLOGY | ||||||
| 06/22/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: VACCINES | ||||||
| 05/21/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: IMMUNOLOGY | ||||||
| 01/26/2023 | Medtronic, Inc. | PROPEL (Device) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 952 | 1,385 | $418,626 | $105,830 |
| 2022 | 6 | 467 | 470 | $180,326 | $44,131 |
| 2021 | 7 | 312 | 441 | $48,337 | $21,655 |
| 2020 | 7 | 318 | 481 | $44,135 | $19,170 |
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 310 | 562 | $131,693 | $33,806 | 25.7% |
| 31579 | Exam to assess movement of vocal cord flaps using an endoscope | Office | 2023 | 164 | 234 | $122,984 | $31,671 | 25.8% |
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2023 | 78 | 101 | $51,327 | $13,429 | 26.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 144 | 144 | $41,558 | $9,232 | 22.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 74 | 74 | $31,739 | $7,599 | 23.9% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 108 | 164 | $20,236 | $5,168 | 25.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 50 | 56 | $18,540 | $4,784 | 25.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 12 | 12 | $445.56 | $109.01 | 24.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 12 | 38 | $103.26 | $31.38 | 30.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 193 | 193 | $83,613 | $20,145 | 24.1% |
| 31579 | Exam to assess movement of vocal cord flaps using an endoscope | Office | 2022 | 79 | 80 | $42,260 | $10,911 | 25.8% |
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2022 | 32 | 33 | $16,904 | $4,202 | 24.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 58 | 58 | $16,878 | $3,965 | 23.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 35 | 36 | $12,037 | $2,803 | 23.3% |
| 69210 | Removal of impacted ear wax | Office | 2022 | 70 | 70 | $8,635 | $2,105 | 24.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 166 | 235 | $28,060 | $11,496 | 41.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 65 | 81 | $12,900 | $5,585 | 43.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 31 | 31 | $4,960 | $3,627 | 73.1% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 14 | 16 | $1,200 | $419.46 | 35.0% |
| 90756 | Vaccine for influenza derived from cell cultures for injection into muscle, quadrivalent, antibiotic free, 0.5ml dosage | Office | 2021 | 11 | 11 | $385.00 | $312.07 | 81.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 11 | 11 | $440.00 | $166.65 | 37.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2021 | 14 | 56 | $392.00 | $49.83 | 12.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 162 | 262 | $26,380 | $11,041 | 41.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 28 | 28 | $4,610 | $2,878 | 62.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 29 | 34 | $4,760 | $2,247 | 47.2% |
About Michael Hultin
Michael Hultin is a Family healthcare provider based in Visalia, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/08/2019. The National Provider Identifier (NPI) number assigned to this provider is 1952866451.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Michael Hultin has received a total of $3,699 in payments from pharmaceutical and medical device companies, with $369.75 received in 2024. These payments were reported across 226 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($3,599).
As a Medicare-enrolled provider, Hultin has provided services to 2,049 Medicare beneficiaries, totaling 2,777 services with total Medicare billing of $190,787. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Visalia, CA
- Active Since 02/08/2019
- Last Updated 02/08/2019
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1952866451
Products in Payments
- Korlym (Drug) $352.10
- TEZSPIRE (Biological) $275.89
- UBRELVY (Drug) $212.88
- NUCALA (Biological) $199.30
- TRINTELLIX (Drug) $171.65
- NURTEC ODT (Drug) $156.12
- VRAYLAR (Drug) $136.39
- DUPIXENT (Biological) $123.63
- Ozempic (Drug) $118.13
- REXULTI (Drug) $117.39
- Aimovig (Biological) $109.02
- JARDIANCE (Drug) $100.03
- BELSOMRA (Drug) $99.15
- BREZTRI (Drug) $96.90
- FARXIGA (Drug) $88.49
- FASENRA (Biological) $87.31
- Vascepa (Drug) $80.55
- EMGALITY (Drug) $75.54
- INSPIRE (Device) $74.79
- TRULICITY (Drug) $71.59
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Visalia
Ms. Pamela Scott, Np, NP
Family — Payments: $106,691
Mrs. Maribel Torres, Fnp, FNP
Family — Payments: $24,292
Brian Brown, Np, NP
Family — Payments: $10,882
Devin Rhyman
Family — Payments: $8,467
Shawn Cardoza, N.p, N.P
Family — Payments: $8,451
Chonny Anderson
Family — Payments: $7,493